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in Fas/APO-1- and TNF Receptor±Induced Cell Death
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dal effect of both receptors through protein±protein in-and David Wallach
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Recent studies implicate a group of cytoplasmic thiolThe Weizmann Institute of Science
Rehovot proteases that are structurally related to the Caenorhab-
ditis elegans protease, CED-3, and the mammalian in-Israel 76100
terleukin-1b (IL-1b)-converting enzyme (ICE) in theonset
of various physiological cell death processes (reviewed
by Kumar, 1995; Henkart, 1996). There are also indica-Summary
tions that these proteases are involved in Fas/APO-1-
and TNF-induced cytotoxicity. Specific peptides andFas/APO-1 and p55 tumor necrosis factor (TNF) recep-
virus-encoded proteins that block protease functiontor (p55-R) activate cellular mechanisms that result in
were found to protect cells from Fas/APO-1- and TNFcell death. Upon activation of these receptors, Fas/
receptor±mediated cytotoxicity (Enari et al., 1995; LosAPO-1 binds a protein called MORT1 (or FADD) and
et al., 1995; Tewari and Dixit, 1995; Xue and Horvitz,p55-R binds a protein called TRADD. MORT1 and
1995; Beidler et al., 1995). In addition, rapid cleavageTRADD can also bind to each other. We have cloned
of specific intracellular proteins, mediated by prote-a novel protein, MACH, that binds to MORT1. This
ase(s) of the ICE/CED-3 family, was observed shortlyprotein exists in multiple isoforms, some of which con-
after Fas/APO-1 or p55-R stimulation (Tewari et al.,tain a region that has proteolytic activity and shows
1995a, 1995b; Martin et al., 1995). The mechanisms ofmarked sequence homology to proteases of the ICE/
activation of the proteases by the receptors have notCED-3 family. Cellular expression of the proteolytic
yet been established. We report the cloning of a novelMACH isoforms results in cell death. Expression of
ICE/CED-3 protease, MACHa, which binds to MORT1;MACH isoforms that contain an incomplete ICE/
its activity appears to be required for Fas/APO-1- andCED-3 region provides effective protection against the
p55-R-induced cytotoxicity. Our results identify a pro-cytotoxicity induced by Fas/APO-1 or p55-R triggering.
teolytic signaling pathway for apoptosis that includesThese findings suggest that MACH is the most up-
ligand-activated receptors (Fas/APO-1 and p55-R),stream enzymatic component in the Fas/APO-1- and
adapter proteins (MORT1 and TRADD), and their target,p55-R-induced cell death signaling cascades.
MACHa, a proteolytic enzyme.
Introduction
Results
Cytotoxicity of lymphocytes is mediated, in part, by in-
teraction of a lymphocyte-produced ligand with Fas/ Two-Hybrid Screening for Proteins That Bind
to MORT1 Reveals a Novel Protein ThatAPO-1 (CD95), a widely occurring cell surface receptor
belonging to the tumor necrosis factor/nerve growth Shares a Sequence Motif with MORT1
Screening of a human B cell cDNA library (Durfee et al.,factor (TNF/NGF) family that can trigger cell death (Na-
gata and Golstein, 1995). Cell killing by mononuclear 1993) by the two-hybrid technique for proteins that bind
to MORT1 yielded cDNA clones of MORT1 itself, re-phagocytes also involves a ligand±receptor pair, TNF
and its p55 receptor (p55-R, CD120a), which are struc- flecting its ability to self-associate (Boldin et al., 1995b),
as well as of TRADD, which binds effectively to MORT1turally related to the ligand of Fas/APO-1 and Fas/
APO-1 (Vandenabeele et al., 1995). Recently, three pro- (Varfolomeev et al., 1996; Hsuet al., 1996). It also yielded
clones of a cDNA with a novel sequence. As describedteins that bind to the intracellular domains of Fas/APO-1
or p55-R, or both, at the region involved in the receptor- below, this protein was later found to occur in multiple
isoforms, some of which contain a region homologousinduced death (the death domains) through heteroas-
sociation of homologous regions found within the pro- to CED-3 and ICE. Following the terminology used for
some of the other ICE/CED-3 homologs, we called theteins have been identified using a yeast two-hybrid
screen. These proteins, MORT1 (or Fas-associating pro- protein ªMACHº (for MORT1-associated CED-3 homo-
log; ªmachº also means ªdeterioratingº in Hebrew). Fortein with death domain [FADD]) (Boldin et al., 1995b;
Chinnaiyan et al., 1995), which binds specifically to reasons explained below, the isoform cloned in the
two-hybrid screen with MORT1 was called ªMACHb1º.Fas/APO-1, TNFR1-associated death domain protein
(TRADD) (Hsu et al., 1995), which binds to p55-R, and Deletion analysis showed that MACHb1 binds to the
N-terminal part of MORT1, which is involved in cell deathreceptor-interacting protein (RIP) (Stanger et al., 1995),
which binds to both receptors, are also capable of bind- induction (Chinnaiyan et al., 1995). MACHb1 also self-
associated in the transfected yeast. However, it did noting to each other (Varfolomeev et al., 1996; Hsu et al.,
1996). Cellular expression of MORT1 mutants lacking bind to several control proteins and, unlike MORT1, was
unable to bind to Fas/APO-1 (Figure 1A).the N-terminal part of the molecule has been shown to
blockcytotoxicity inductionby Fas/APO-1 orp55-R (Hsu Expression of MACHb1 molecules in mammalian cells
yielded a 34 kDa protein that bound to MORT1 mole-et al., 1996; Chinnaiyan et al., 1996; M. P. B., T. M. G.,
and D. W., unpublished data), indicating that this cules coexpressed with it (Figure 1C). It was also able
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Figure 1. Binding of MACH to MORT1
(A) Interactions within transfected yeast. In-
teractions of MORT1, its deletion constructs,
MACHb1, and MACHa1, a MACHa1 mutant
in which the catalytic cysteine residue (Cys-
360) is replaced by Ser (MACHa1(C360S)),
and the intracellular domain of human Fas/
APO-1 (Fas-IC) within transfected yeast were
assessed by a two-hybrid b-galactosidase
expression filter assay. The results are ex-
pressed as the time required for development
of strong color. None of the examined inserts
interacted with control proteins, including the
intracellular domains of human p55 TNF re-
ceptor, p75 TNF receptor, and CD40, and
lamin, cyclin D, and empty GAL4 vectors.
(B) and (C) Interactions within mammalian cells. MORT1 fused at
its C-terminus with the HA epitope (MORT1±HA) was expressed in
human embryonic kidney 293-EBNA cells, alone or together with
MACHb1 or MACHa1(C360S), or both. MORT1±HA was immunopre-
cipitated from lysates of the cells using an anti-HA monoclonal
antibody. The immunoprecipitated MORT1±HA protein (B) and the
coprecipitating MACH molecules (C) were detected by Western blot
analysis using rabbit anti-MORT1 and anti-MACHb1 antisera, re-
spectively. MORT1±HA appears as a double band (Boldin et al.,
1995b; Kischkel et al., 1995), probably because of differing degrees
of phosphorylation of the MORT1 molecules (Kischkel et al., 1995).
to bind to a glutathione-S transferase (GST)±MORT1 significant amounts of MORT1. Conversely, resting
peripheral blood mononuclear leukocytes, in whichfusion protein in vitro (data not shown).
Comparison of the amino acid sequences in MACHb1 MORT1 expression is very low, were found to express
MACH at high levels. Lectin activation of the leukocytesand MORT1 (Figures 2A and 2B) revealed a shared se-
quence motif, which we called the ªMORT module,º results in a marked change in the size pattern of MACH
transcripts, along with an induction of MORT1 (E. Varfol-occurring once in MORT1 and twice in MACHb1. The
same motif is also found in PEA-15, an astrocyte phos- omeev, M. P. B., and D. W., unpublished data).
To determine the structural basis for the size hetero-phoprotein of unknown function (Figure 2B). This motif
is distinct from the death domain motif through which geneity of the MACH transcripts, we screened cDNA
libraries for transcripts that hybridize with the MACHb1MORT1 binds to Fas/APO-1 (Boldin et al., 1995b; Chin-
naiyan et al., 1995). Preliminary data suggest that the cDNA probe. Using reverse transcriptase±polymerase
chain reaction (RT±PCR), we also attempted to cloneMORT motif is involved in the binding of MACHb1 (and
of other MACH isoforms) to MORT1 (data not shown). related transcripts from tumor cell lines. Screening re-
vealed the existence of multiple MACH isoforms, most
probably produced by alternative splicing (see FiguresMACH Occurs in Multiple Isoforms
Northern blot analysis revealed size heterogeneity of 2A and 2C).
All the MACH isoforms shared a common 182 aminoMACH transcripts, ranging between 2.85 kb and 3.5 kb.
Both the amounts and the sizes of the transcripts varied acid N-terminal region (which encompasses the MORT
modules), but had different C-termini. Three isoforms,among different human tissues (Figure 3A), and were
not correlated with the expression of MORT1 (Figure defined as subgroup a, have a C-terminus that closely
resembles proteases of the ICE/CED-3 family (see be-3B; Chinnaiyan et al., 1995) or of Fas/APO-1 (Watanabe
et al., 1992; Leithauser et al., 1993). In the testis and low). Four others, defined as subgroup b, have different
C-termini owing to alteration in the reading frame. Twoskeletal muscle, for example, MACH transcripts were
barely detectable, even though these tissues express (MACHb1 and MACHb2) share the C-terminus found in
A Novel ICE/CED-3 Homolog That Binds to MORT1
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Figure 2. Amino Acid Sequences of the MACH Isoforms, and Conserved Motifs Found in the Proteins
(A) Colinear amino acid sequence alignment of three of the MACH isoforms, CED-3 (Ellis and Horvitz, 1986; Yuan et al., 1993), and the known
human proteases of the ICE/CED-3 protease family: CPP32 (Fernandes-Alnemri et al., 1994), also called apopain (Nicholson et al., 1995), and
(Figure 2 continued on next page)
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(Figure 2 continued from previous page)
Yama (Tewari et al., 1995b), Mch2a (Fernandes-Alnemri et al., 1995), Ich-1 (Wang et al., 1994) (Ich-1 is the human homolog of the mouse
Nedd2 protein, Kumar et al., 1994), ICE rel-III (Munday et al., 1995), ICE rel-II (Munday et al., 1995), also called TX and Ich2 (Faucheu et al.,
1995; Kamens et al., 1995), and ICE (Thornberry et al., 1992; Cerretti et al., 1992). Amino acid residues are numbered to the right of each
sequence. Dotted lines indicate gaps in the sequence to allow optimal alignment. Amino acids that are identical in at least three members of
the ICE/CED-3 protease family shown are boxed. The MORT modules upstream of the ICE/CED-3 homology region are shaded. The three
amino acid blocks downstream of the MORT module region (blocks 1±3, see text for explanation) are denoted by overlinings. Within the ICE/
CED-3 homology region, amino acids aligning with residues within ICE that were implicated in catalytic activity by X-ray crystallography are
denoted as follows: the residues putatively involved in catalysis, corresponding to His-237, Gly-238, and Cys-285 in ICE, are heavily shaded
and marked by closed circles below the alignment. The residues constituting the binding pocket for the carboxylate side chain of the P1 Asp,
corresponding to Arg-179, Gln-283, Arg-341, and Ser-347 in ICE, are less heavily shaded and marked by open circles below the alignment.
The QACRG motif, which is conserved in all previously described proteases of the ICE/CED-3 family, is lightly shaded. Residues proximal to
P1±P4 residues of the substrate are marked by triangles below the alignment. Known and suggested Asp-X cleavage sites and potential sites
of cleavage found at similar locations in MACH are shaded but not boxed. Arrows indicate the N- and C-terminal ends of the p20 and p10
subunits of ICE and of the p17 and p12 subunits of CPP32. The C-termini of the proteins are denoted by asterisks. Amino acid residues in
the unique C-terminal sequences of MACHb1 and MACHb3 are written in italics.
(B) The MORT module: sequence homology of the modules in MORT1, MACHb1 (as well as in the other MACH isoforms), and the PEA-15
gene (GenBank accession number X86809). Identical and similar residues are denoted by boxed and shaded areas, respectively. Sequence
identity between the four modules ranged between 18%±38%, and sequence similarity between 47%±56%.
(C) Diagrammatic representation of the various MACH isoforms. Coding regions are represented as boxed areas. The various domains within
the coding regions are denoted by different shadings as follows: the MORT modules by the checkered areas; the three amino acid sequence
blocks, which occur in different combinations in the isoforms, indicated by numbers as in (A), by the heavily shaded, medium shaded, and
the dark striped areas. Positions of the residues in the ICE/CED-3 homology region implicated in the catalytic activity of ICE are shown. The
catalytic cysteine residue is indicated by a star. Those parts of the MACHa1 nucleotide sequence that are missing in the sequences of other
isoforms are indicated in the diagrams of the latter isoforms by V-shaped connecting lines. The lengths of these cDNA regions, which probably
correspond to distinct exons, are indicated below the diagram of MACHa1. Lack of the 65 nt that in MACHa1 encode for block 2 causes
alteration in MACHb1 and MACHb2 of the reading frame of the nucleotides that encode for block 3. In those isoforms, therefore, these
nucleotides encode other amino acids, which together constitute their unique C-terminal region, indicated by the most lightly shaded areas.
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Figure 3. Identification of the MACH Tran-
scripts
Northern blot analysis of poly(A)1 RNA (2 mg
per lane) of various human tissues using
cDNA probes corresponding in (A) to nucleo-
tides 190±732 in MACHb1 (a region common
to all MACH isoforms cloned), and in (B) to
nucleotides 112±852 in MORT1.
the isoform initially cloned by the two-hybrid screen, acid residue at P19, whereas other structural features of
the substrate, including the nature of the residues atand two (MACHb3 and MACHb4) share a different
C-terminus. positions P2±P4, are less uniform. Accordingly, the active
site residues involved in catalysis and in forming theThe regions between the MORT modules and the se-
quences defining subgroups a and b varied from one binding pocket for the carboxylate side chain of the
P1 Asp are conserved in these proteases. As shownisoform to another. However, close examination showed
that these intermediate regions consist of different com- in Figure 2A, these residues are also conserved in
MACHa1. One exception is a conservative change ofbinations of the same three amino acid sequence blocks
(see Figure 2, blocks 1, 2, and 3). Ser to Thr at the site corresponding to Ser-347 in ICE.
Another slight, yet potentially important, sequence dif-
ference between the MACHa isoforms and other mem-Some of the MACH Isoforms Contain
a ICE/CED-3 Homology Region bers of the protease family is the substitution of Gln for
the Arg found in ICE in position 286. In addition, someA data bank search revealed that the C-terminal part of
the MACHa isoforms, including block 3 and the se- of the residues in the MACHa isoforms at the sites lo-
cated near the substrate P2±P4 residues differ from thosequence extending downstream of it, closely resembles
proteases of the ICE/CED-3 family. Figure 2A presents found in other ICE/CED-3 proteins.
Second, proteases of the ICE/CED-3 family containa sequence comparison of this region in MACH with
various known proteins of this family from human sites of cleavage by proteases of this family. Indeed,
several of the proteasesare knownto be self-processed,sources and the C. elegans CED-3 protein. The region in
MACHmost closely resembles CPP32, with 41% identity and depend upon this processing for maximal catalytic
activity. Their fully bioactive form is composed of twoand 62% homology, and CED-3, with 34% identity and
56% homology. It is less similar to ICE, with 28% identity noncovalently associated cleavage products that differ
in size (p20 and p10 in ICE; p17 and p12 in CPP32,and 50% homology, and its closely related homologs,
ICE rel-II and ICE rel-III. marked by arrows in Figure 2A). The presence of poten-
tially autocleavable sites in other members of the familyThe following two points of similarity seem to be par-
ticularly significant: suggests that they are also subject to processing. Such
sites occur in MACHa1 at almost the same locations asFirst, all known proteases of the ICE/CED-3 family
cleave proteins at sites defined by the occurrence of in CPP32. The site in MACHa1 corresponding to the
N-terminus of the p17 subunit of CPP32 is located inAsp at the P1 position and a small hydrophobic amino
On the other hand, in MACHb3 and MACHb4 the reading frame of block 3 is maintained, but absence of the nucleotides that encode the ICE/
CED-3 region and part of the 39 noncoding region results in alteration of the reading frame of nucleotides further downstream. Because of
this alteration, the most 59 part of this noncoding downstream region does encode 10 amino acids, which constitute the C-terminal region
unique to these two isoforms, indicated by the most light striped areas. As indicated in the figure, only partial cDNA clones of MACHa3 and
MACHb2 were obtained.
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the second conserved amino acid block, just a few
amino acids upstream of the N-terminus of the ICE/
CED-3 homology region (below Asp-216). As with all
other members of the ICE/CED-3 family known to be
cleaved, the site in MACHa1 corresponding to the point
of cleavage between the two subunits of CPP32 is lo-
cated a few amino acids downstream of the catalytic
cysteine residue (below Asp-374).
MACHa1 Binds to MORT1 and to MACHb1
To determine whether MACHa1 can bind to MORT1 as
MACHb1 does, we first examined the interaction of the
proteins within transfected yeast. As shown below,
MACHa1 was cytotoxic to mammalian cells. It was also
cytotoxic to the yeast, particularly when expressed in
the activation domain (AD) vector (the expression level
of which is higher than that of the DNA-binding domain
[DBD] vector). On the other hand, MACHa1 in which the
catalytic cysteine residue, Cys-360, was replaced with
Ser (MACHa1(C360S)) was not cytotoxic to either
mammalian cells (see below) or yeast. Like MACHb1,
MACHa1(C360S) bound in transfected yeast to MORT1
and also to itself. It also bound to MACHb1. Also, yeast
expressing the wild-type MACHa1 together with MORT1
or MACHb1 exhibited interaction of the transfected pro-
teins. The intensity of the lacZ product color varied,
however, among the yeast colonies; in yeasts trans-
fected with MACHa1 in both the AD and the DBD vec-
tors, no color product was observed, probably because Figure 4. Protease Activity of the ICE/CED-3 Homology Region in
of the cytotoxic effect of the wild-type MACHa1 (see MACHa
Figure 1A). (A) Kinetics of cleavage of the PARP sequence±derived fluorogenic
Both MACHa1(C360S) and MACHb1 coimmunopreci- substrate, Ac-DEVD-AMC (50 mM), by extracts of E. coli expressing
a GST fusion protein of the ICE/CED-3 homology region in MACHa1pitated with MORT1 from lysates of human embryonic
(Ser-217 through the C-terminus of the protein, indicated by thekidney 293-Epstein±Barr virus nuclear antigen (EBNA)
filled boxes) as compared with the lack of cleavage by extracts ofcells, indicating that they bind to MORT1 also in mam-
bacteria expressing GST fusion products of the full-length MACHa1,
malian cells (see Figure 1C). indicated by open circles, or of the ICE/CED-3 homology region in
which Cys-360 was replaced by Ser, indicated by inverted open
triangles, or by extracts of bacteria expressing GST fusion products
The ICE/CED-3 Homology Region in MACH of either of the two potential proteolytic products of the ICE/CED-3
homology region (Ser-217 through Asp-374, indicated by open trian-Has Proteolytic Activity
gles, and Ser-375 through Asp-479, the C-terminus of the protein,Lysates of Escherichia coli in which we had expressed
indicated by filled-in triangles ).the MACHa ICE/CED-3 homology region in fusion with
(B) Substrate concentration dependence of the cleavage of Ac-
GST were examined for their ability to cleave fluorogenic DEVD-AMC. The substrate was incubated for 180 min with extracts
peptide substrates, previously shown to be cleaved by of bacteria expressing the GST fusion product of the MACHa1 ICE/
other ICE/CED-3 homologs (Figure 4). The lysates ef- CED-3 homology region, indicated by filled-in boxes. Cleavage of
this substrate by the extracts was inhibited in the presence of io-fectively cleaved acetyl-Asp-Glu-Val-Asp-a-(4-methyl-
doacetic acid (5 mM, indicated by open boxes). Ac-YVAD-AMC, acoumaryl-7-amide) (Ac-DEVD-AMC), whose sequence
fluorogenic substrate corresponding to an ICE cleavage site in thecorresponds to a site in the nuclear protein poly(ADP-
IL-1b precursor, was not cleaved (indicated by filled-in circles).
ribose) polymerase (PARP), which is cleaved in cells
following Fas/APO-1 stimulation (Tewari et al., 1995b) as
well as in other apoptotic processes (Kaufmann, 1989;
of the two potential cleavage products of the ICE/Kaufmann et al., 1993; Lazebnik et al., 1994). This activity
CED-3 homology region.was blocked by iodoacetic acid (5 mM), confirming that
None of the tested lysates showed proteolytic activityit is mediated by a thiol protease. No cleavage was
towards acetyl-Tyr-Val-Ala-Asp-a-(4-methyl-coumaryl-observed with lysates containing the GST-fused MACH
7-amide) (Ac-YVAD-AMC), an ICE cleavage site in theICE/CED-3 homology region in which the catalyticcyste-
IL-1b precursor (Thornberry et al., 1992).ine residue Cys-360 was replaced by Ser. Also, lysates
from bacteria that expressed the full-length MACHa1
protein as a GST fusion protein did not cleave Ac-DEVD- MACH Molecules That Contain the ICE/CED-3
Homology Region Can Mediate Cell DeathAMC, probably because of the absence of bacterial en-
zymes capable of processing the full-length molecule. Embryonic kidney 293-EBNA and breast carcinoma
MCF7 cells transfected with an expression vector ofNor did cleavage occur with lysates containing either
A Novel ICE/CED-3 Homolog That Binds to MORT1
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Figure 5. Cell Death Mediation by MACHa1
and MACHa2
(A) Morphology of human embryonic kidney
293-EBNA cells transiently expressing the in-
dicated MACH isoforms. The arrows point to
apoptotic cells. Photographs were taken 26
hr after transfection.
(B) Quantification of MACH-induced death of
the 293-EBNA and MCF7 cells by determina-
tion of the portion of b-galactosidase-expres-
sing cells exhibiting apoptotic morphology 20
hr after transfection of the indicated con-
structs. Data are from three independent ex-
periments with the 293-EBNA cells and two
independent experiments with the MCF7
cells. They are expressed as the mean per-
centage of the blue cells exhibiting signs of
apoptosis as a fraction of the total number
of blue cells counted (about 500 cells per
sample). The expression construct of MA-
CHa3 used in the experiments presented in
this figure and in Figure 6 was created by
reconstituting the missing N-terminal part of
this isoform with the corresponding part of
MACHa1.
either MACHa1 or MACHa2 exhibited massive cell or MACHa1(C360S) (Figure 5). Cells transfected with
MACHa1 together with these vectors also exhibited verydeath, manifested by cell rounding, blebbing, contrac-
tion, and finally detachment of cells from the dish (Figure little cell death, indicating that MACH molecules with an
incomplete ICE/CED-3 region have a negative dominant5A, top; data not shown). By 20 hr after transfection,
most of the transfected cells exhibiting b-galactosidase effect on the activity of the wild-type molecules (data
not shown). Cultures expressing MACHb1, which lacksstaining (used as a transfection marker) showed con-
densed morphology typical of apoptosis (Figure 5B). the ICE/CED-3 region, exhibited some slight cell death
(Figure 5B). In HeLa cells, this effect of MACHb1 was,No death (beyond the slight amount observed in con-
trol cells transfected with an empty expression vector) for some reason, more pronounced, and also MACHa3,
MACHa1(1±415), and MACHa1(C360S) were somewhatoccurred in 293-EBNA or MCF7 cells transfected with
the expression vectors for MACHa3, MACHa1(1±415), cytotoxic (Figures 6C and 6D; data not shown).
Cell
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Figure 6. MACHa Molecules That Contain a Nonfunctional ICE/CED-3 Region Block Cell Death Induction by Fas/APO-1 and p55-R
(A) Morphology of 293-EBNA cells in which cell death was induced by transient expression of a chimera comprised of the extracellular domain
of the p55-R (amino acids 1±168) fused to the transmembrane and intracellular domains of Fas/APO-1 (amino acids 153±319) (p55-Fas
chimera), or by expression of the p55-R, and of cells that were protected from these cytotoxic effects by their simultaneous transfection with
MACHa1(C360S). Photographs were taken 26 hr after transfection.
(B) Quantification of death induced in 293-EBNA cells by their transfection with p55-Fas chimera or with p55-R, together with an empty vector,
a MORT1 deletion mutant lacking the MACH-binding region (MORT1(92±208)), or MACHa molecules containing a nonfunctional ICE/CED-3
region.
(C) Death of HeLa cells that transiently express Fas/APO-1, induced by treatment with anti-Fas/APO-1 antibody and cycloheximide, and its
prevention by cotransfection of MORT1(92±208), MACHa1(C360S), or MACHa3.
(D) Death of HeLa cells induced by treatment with TNF and cycloheximide, and its prevention as in (C). Data are from at least two independent
experiments and are expressed as in Figure 5.
Blocking of MACHa Function Interferes with Cell that MACHa is a necessary component of both the Fas/
APO-1- and the p55-R-induced signaling cascades forDeath Induction by Fas/APO-1 and p55-R
To assess the contribution of MACHa to Fas/APO-1 and cell death.
p55-R cytotoxicity, we expressed MACHa3, as well as
the nonfunctional MACHa1 mutants, MACHa1(1±415) Discussion
and MACHa1(C360S), in cells that were induced to ex-
hibit this cytotoxicity. p55-R-induced cytotoxicity was Like other receptor-induced effects, cell death induction
by the TNF receptors and Fas/APO-1 occurs via a seriestriggered in 293-EBNA cells by transient overexpression
of this receptor (Boldin et al., 1995a), and Fas/APO-1 of protein±protein interactions, leading from ligand±
receptor binding to the eventual activation of enzymaticcytotoxicity by overexpression of chimeric molecules
comprising the extracellular domain of the p55-R and effector functions, which in the case of these particular
receptors results in cell death. Previous studies havethe transmembrane and intracellular domains of Fas/
APO-1. The chimera was considerably more cytotoxic elucidated nonenzymatic protein±protein interactions
that initiate signaling for cell death: binding of trimericthan the normal Fas/APO-1 (data not shown). We also
induced cytotoxic activity in HeLa cells by treating them TNF or the Fas/APO-1 ligand molecules to the receptors,
the resulting interactions of their intracellular domainswith TNF or anti-Fas/APO-1 antibody in the presence
of the protein synthesis blocker cycloheximide. In all (Brakebusch et al., 1992; Tartaglia et al., 1993; Itoh and
Nagata, 1993) (augmented by a propensity of the deathsystems examined, MACHa3 and the nonfunctional
MACHa1 mutants provided effective protection against domain motifs to self-associate) (Boldin et al., 1995a),
and induced binding of two cytoplasmic proteins (whichthe receptor-induced cytotoxicity (Figure 6). Such pro-
tection was also observed, as previously reported (Hsu can also bind to each other) to the intracellular domains
of the receptors: MORT1 (orFADD) toFas/APO-1 (Boldinet al., 1996; Chinnaiyan et al., 1996), in cells transfected
with a MORT1 N-terminal deletion mutant lacking the et al., 1995b; Chinnaiyan et al., 1995, Kischkel et al.,
1995) and TRADD to p55-R (Hsu et al., 1995, 1996).MACH-binding region. These protective effects indicate
A Novel ICE/CED-3 Homolog That Binds to MORT1
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Figure 7. Diagrammatic Representation of the Receptor and Target Protein Interactions Participating in Induction of Cell Death by Fas/APO-1
and p55-R
Death domain module is indicated by striped areas; MORT module is indicated by lightly shaded areas; ICE/CED-3 homology region is
indicated by heavily shaded areas.
Here, we describe a protease of the ICE/CED-3 family, MACHa to Fas/APO-1 brings together several MACH
molecules, or induces conformational changes in them,MACHa, that binds to MORT1 and initiates cell death.
MACHa activity appears to constitute the most up- and that these changes either trigger autolytic pro-
cessing of MACHa or make MACHa susceptible tostreamenzymatic step in thecascade of signalingfor the
cytocidal effects of Fas/APO-1 and p55-R (Figure 7). cleavage by other proteases. Stimulation of p55-R may
trigger self-processing of MACHa in a similar, thoughThe regulatory mechanisms of MACHa activity remain
to be clarified. Other ICE/CED-3 proteases were shown less direct manner, by bringing together several TRADD
molecules, or inducing a conformational change in them,to exhibit full activity only after proteolytic processing,
which occurs either by self-cleavage or via their cleav- which, in turn, induces a change in the conformation or
state of aggregation of MORT1 and its associated MACHage by other proteases (reviewed by Kumar, 1995; Hen-
kart, 1996). Our observation that lysates of bacteria that molecule.
The substrate specificity of MACHa seems to beexpress GST±MACHa1 molecules do not possess enzy-
matic activity, as opposed to the activity observed in rather death oriented. Although it could cleave a
substrate peptide corresponding to a cleavage site inlysates of bacteria that express the ICE/CED-3 homol-
ogy region, suggests that processing is also required for the death substrate PARP (Ac-DEVD-AMC), MACHa
showed no proteolytic activity towards a peptide corre-MACHa activity. The way in which MACHa processing
occurs within the mammalian cell, and how this pro- sponding to the site of processing of the IL-1b precursor
by ICE (Ac-YVAD-AMC). Identification of the cellular pro-cessing is brought about by Fas/APO-1 or p55-R trig-
gering, is not known. MORT1 has been shown to bind teins that serve as substrates for cleavage by MACHa
will elucidate the more downstream events in death in-in cells to activated Fas/APO-1 together with some other
proteins (Kischkel et al., 1995). These proteins are likely duction by this protease. Likely substrates for MACHa
cleavage are other members of the ICE/CED-3 family,to include MACHa1 and other MACH isoforms. It seems
plausible that the binding of MORT1 in association with such as CPP32 and ICE. Some of these proteases are
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indeed processed after Fas/APO-1 or TNF receptor trig- the TNF receptors to trigger other tissue-damaging ac-
tivities, aberrations in the function of these receptorsgering (Miura et al., 1995; Schlegel et al., 1996; Chinnai-
yan et al., 1996). Perhaps, proteases that do not belong could be particularly deleterious to the organism. In-
deed, both excessive and deficient functioning of theseto the ICE/CED-3 family are also activated by MACHa,
either directly or through the action of other ICE/CED-3 receptors have been shown tocontribute to pathological
manifestations of various diseases (Vassalli, 1992; Na-proteases. Involvement of multiple proteases in the cell
death process is consistent with the reported ability of gata and Golstein, 1995). Identifying the molecules that
participate in the signaling activity of the receptors, andinhibitors of various proteases, including inhibitors of
serine proteases and an inhibitor of ICE cleavage as finding ways tomodulate theactivity of thesemolecules,
could direct new therapeutic approaches. In view of thewell as antisense ICE cDNA, to protect cells from Fas/
APO-1- and TNF receptor±induced toxicity (Weitzen and suspected central role of MACHa in Fas/APO-1- and
TNF-mediated toxicity, it seems particularly importantGranger, 1980; Ruggiero et al., 1987; Enari et al., 1995;
Los et al., 1995). to design drugs that can block the proteolytic function
of MACHa, as was done for some other proteins of theA variety of other enzymes, including phospholipases,
sphyngomyelinases, and protein kinases, may partici- ICE/CED-3 family. The unique sequence features of the
ICE/CED-3 homolog within MACHa molecules couldpate in cell death induction by the TNF receptors and
Fas/APO-1 (see, e.g., Eischenet al., 1994; Vandenabeele permit the design of drugs that would specifically af-
fect its activity. Such drugs could provide protectionet al., 1995; Cifone et al., 1995, and references therein).
Some of these enzymes may become activated by the from excessive immune-mediated cytotoxicity involving
MACHa, without interfering with the physiological cellproteolytic cleavage initiated by MACHa. It also seems
possible, however, that at least part of these other death processes in which other members of the ICE/
CED-3 family are involved.death-related activities are stimulated by distinct sig-
naling routes, independently of MACHa stimulation.
Involvement of more than one signaling cascade in the Experimental Procedures
inductionof cell death, some common top55-R and Fas/
Cloning of MACHb1 and Study of Its Binding PropertiesAPO-1 and some induced by only one of them, would
by Two-Hybrid b-Galactosidase Expression Testbe consistent with reports on both shared and distinct
MACHb1 was cloned by two-hybrid screening (Fields and Song,
features of cell death processes induced by the two 1989) of a GAL4 AD-tagged human B cell library (Durfee et al., 1993)
receptors (Grell et al., 1994; Schulze-Osthoff et al., 1994; for proteins that bind to MORT1, using the HF7c yeast reporter
Wong and Goeddel, 1994; Clement and Stamenkovic, strain (Clontech, Palo Alto, CA). Screening was performedaccording
to the Matchmaker Two-Hybrid System Protocol (Clontech) in the1994).
presence of 5 mM 3-aminotriazole. The binding properties ofMACH is expressed in different tissues at markedly
MACHb1, as well as of other examined proteins, were assessed indifferent levels and apparently also with different isotype
the yeast SFY526 reporter strain (Clontech), using the pGBT9 GAL4-
patterns. These differences probably contribute to the DBD and pGAD GH GAL4-AD vectors. Quantification of the binding
tissue-specific features of response to the Fas/APO-1 li- in yeast by the b-galactosidase expression filter assay was per-
gand and TNF. As in the case of other ICE/CED-3 homo- formed as described (Boldin et al., 1995b).
logs (Wang et al., 1994; Alnemri et al., 1995), MACH
isoforms containing incomplete ICE/CED-3 regions Cloning of Other MACH Isoforms
MACHa1 and MACHa2 were cloned from a Charon BS cDNA library(e.g., MACHa3) are found to inhibit the activities of coex-
derived from the mRNA of human thymus (donated by P. Sankha-pressed MACHa1 or MACHa2 molecules; they are also
varam, Yale University). The library was screened under stringentfound to block death induction by Fas/APO-1 and
conditions with a MACHb1 cDNA probe, labeled using a random-
p55-R. Expression of such inhibitory isoforms in cells priming kit (Boehringer Mannheim). The other MACH isoforms were
may constitute a mechanism of cellular self-protection cloned by RT±PCR, performed on total RNA from Raji (MACHa1,
MACHa2, MACHa3, MACHb3, and MACHb4) and Daudi (MACHa2,against Fas/APO-1- and TNF-mediated cytotoxicity. The
MACHb2, MACHb3, and MACHb4) human lymphoblastoid cells. Re-wide heterogeneity of MACH isoforms, which greatly
verse transcriptase reaction was performed with an oligo(dT)exceeds that observed for any of the other proteases
adapter primer (59-GACTCGAGTCTAGAGTCGAC(T)17±39) and theof the ICE/CED-3 family, should allow a particularly fine
SuperScript II reverse transcriptase (GIBCO BRL), used according
tuning of the function of the active MACH isoforms. to the instructions of the manufacturer. The first round of PCR was
It is possible that some of the MACH isoforms serve performed with the Expand Long TemplatePCR System (Boehringer
additional functions. The ability of MACHb1 to bind to Mannheim), using the following sense and antisense primers:
59-AAGTGAGCAGATCAGAATTGAG-39, corresponding to nucleo-both MORT1 and MACHa1 suggests that this isoform
tides 521±542 of the MACHb1 cDNA, and 59-GACTCGAGTCTAGAGmight enhance the activity of the enzymatically active
TCGAC-39, respectively. The second round was performedwith Ventisoforms. The mild cytotoxicity observed in 293-EBNA
polymerase (New England Biolabs) using the following sense and
and MCF7 cultures transfected with this isoform and antisense nested primers: 59-GAGGATCCCCAAATGCAAACTGGAT
the rather significant cytotoxic effect that it exerts in GATGAC-39 and 59-GCCACCAGCTAAAAACATTCTCAA-39, which
HeLa cells probably reflect activation of endogenously correspond to nucleotides 575±597 and nucleotides 930±953 of
MACHb1 cDNA, respectively. To confirm that MACHb3 andexpressed MACHa molecules upon binding to the
MACHb4 have initiation codons, we cloned a more 59 sequence oftransfected MACHb1 molecules. Conceivably, some of
these isoforms from the RNA of Raji cells. The RT±PCR reaction,the MACH isoforms could also act as docking sites for
performed using the oligo(dT) adapter primer as described above,
molecules that are involved in other noncytotoxic effects was followed by two rounds of PCR (with Vent polymerase) (NEB),
of Fas/APO-1 and TNF receptors. using the following sense and antisense oligonucleotides:
Owing to the unique ability of Fas/APO-1 and TNF 59-TTGGATCCAGATGGACTTCAGCAGAAATCTT-39 and 59-ATTCT
CAAACCCTGCATCCAAGTG-39, which correspond to nucleotidesreceptors to cause cell death, as well as the ability of
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188±210 and nucleotides 914±937 in MACHb1, respectively. (The Cell Death Assays
293-EBNA, MCF7 human, and HeLa cells (clone HtTA-1, obtainedlatter oligonucleotide is specific to the b isoforms.) Among the
clones obtained in this way, those found to contain the nucleotides from Dr. H. Bujard) were grown in Dulbecco's modified Eagle's
minimal essential medium supplemented with 10% fetal calf serum,encoding for the amino acids of block 2 (whose presence distin-
guishes MACHb3 and MACHb4 from MACHb1 and MACHb2; see nonessential amino acids, 100 U/ml penicillin, and 100 mg/ml strep-
tomycin. Cells (5 3 105 293-EBNA cells, 3 3 105 MCF7 cells, or 3 3legend for Figure 2C) were fully sequenced. Nucleotide sequences
in all cloned isoforms were determined in both directions by the 105 HeLa cells in dishes [6 cm]) were transiently transfected, using
the calcium phosphate precipitation method, with the cDNAs ofdideoxy-chain termination method. Only partial cDNA clones of
MACHa3 and MACHb2 were obtained. the indicated proteins together with the b-galactosidase expression
vector. In the experiments presented in Figure 5, each dish was
transfected with 3.5 mg of the indicated MACH construct and 1.5
Northern Blot Analysis mg of pSV±b-gal. In the experiments presented in Figures 6A, 6B,
cDNA probes were radiolabeled with the random-prime kit (Boeh- and 6C, each dish was transfected with 2.5 mg of the p55-R, p55-
ringer Mannheim) and applied for analysis of human multiple tissue Fas chimera (for 6A and 6B), or Fas/APO-1 (for 6C) constructs, 2.5
blots (Clontech) according to the instructions of the manufacturer. mg of the indicated MACH or MORT1 construct (or, as control, empty
vector), and 1.5 mg of pSV±b-gal. In the experiment of Figure 6D,
each dish was transfected with 5 mg of the indicated MACH orExpression Vectors
MORT1 construct (or, as control, empty vector) and 1.5 mg ofAll cDNA sequences used were of human origin. The deletion mu-
pSV±b-gal. Cells were rinsed 6±10 hr after transfection. The 293-tants, the GST fusions, and the p55-R-Fas chimera were produced
EBNA and MCF7 cells were incubated for a further 18 hr withoutby PCR or conventional cloning techniques, or both, and the point
additional treatment. The HeLa cells were incubated for 26 hr aftermutants by oligonucleotide-directed mutagenesis. Proteins of the
transfection and then for 5 hr in the presence of either anti-Fas/Fas/APO-1 orp55-R signaling cascades wereexpressed in mamma-
APO-1 antibody (CH11, 0.5 mg/ml) or TNF (100 ng/ml), together withlian cells using the pcDNA3 expression vector (Invitrogen). b-galac-
cycloheximide (10 mg/ml). The extent of cell death at the end of thetosidase was expressed using the pSV±b-gal vector (Promega).
incubation periods was assessed by determination of b-galactosi-
dase expression, as described by Kumar et al. (1994).
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